English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 849653 Online Users : 668
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
洪文俊
--會議論文/會議摘要
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
洪文俊
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
會議論文/會議摘要
[
5
/5]
期刊論文
[
83
/83]
Siblings
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉滄梧
[
119
/125]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張俊彥
[
234
/254]
張光裕
[
69
/79]
張憶壽
[
103
/106]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蔡慧珍
[
66
/71]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳尚鴻
[
45
/48]
陳振陽
[
72
/72]
陳立宗
[
443
/510]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
464
/471]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
Community Statistics
近3年內發表的文件:13(14.77%)
含全文筆數:88(100.00%)
文件下載次數統計
下載大於0次:88(100.00%)
下載大於100次:85(96.59%)
檔案下載總次數:33759(0.63%)
最後更新時間: 2024-11-28 13:36
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Increased blood CSF3R+myeloid-deriv...
Neuron-derived neurotensin promotes...
RNF43 inactivation enhances the B-R...
Pancreatic cancer cell-derived sema...
ARID1A loss in pancreas leads to is...
PTEN regulates invasiveness in panc...
Skp2-mediated Zeb1 expression facil...
Protein arginine methyltransferase ...
Reprogramming of sentinel lymph nod...
Mitochondrial phosphoenolpyruvate c...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-50 of 88. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-06-30
Increased blood CSF3R+myeloid-derived suppressor cell is a predictor for breast cancer recurrence
American Journal of Cancer Research. 2024 Jun 30;14(6):3171-3185.
2024-03
RNF43 inactivation enhances the B-RAF/MEK signaling and greates a combinatory therapeutic target in cancer cells
Advanced Science. 2024 Mar;11(12):Article number e2304820.
2024-02-15
Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway
American Journal of Cancer Research. 2024 Feb 15;14(2):448-466.
2023-08-15
Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination
American Journal of Cancer Research. 2023 Aug 15;13(8):3417-3432.
2023-02-01
Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers
Cancer Letters. 2023 Feb 1;554:Article number 216008.
2023-01-20
ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance
iScience. 2023 Jan 20;26(1):Article number 105881.
2023-01
Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway
Cancer Medicine. 2023 Jan;12(2):1588-1601.
2022-12-15
Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway
Life Sciences. 2022 Dec 15;311(Part A):Article number 121135.
2022-11-06
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation
Journal of Biomedical Science. 2022 Nov 06;29:Article number 92.
2022-10-20
Reprogramming of sentinel lymph node microenvironment during tumor metastasis
Journal of Biomedical Science. 2022 Oct 20;29:Article number 84.
2022-04-18
The trinity: Interplay among cancer cells, fibroblasts, and immune cells in pancreatic cancer and implication of CD8(+) T cell-orientated therapy
Biomedicines. 2022 Apr 18;10(4):Article number 926.
2022-02-24
Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway
International Journal of Molecular Sciences. 2022 Feb 24;23(5):Article number 2608.
2022-02-15
Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1
American Journal of Cancer Research. 2022 Feb 15;12(2):713-728.
2021-01
Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth
British Journal of Cancer. 2021 Jan;124(2):484-493.
2021-01
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
Cancer Science. 2021 Jan;112(1):243-253.
2020-11-28
Comprehensive transcriptomic analysis identifies ST8SIA1 as a survival-related sialyltransferase hene in breast cancer
Genes. 2020 Nov 28;11(12):Article number 1436.
2020-10-19
Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes
OncoImmunology. 2020 Oct 19;9(1):Article number 1830513.
2020-01
Prognostic role of RECK in pathological outcome-dependent buccal mucosa squamous cell carcinoma
Oral Diseases. 2020 Jan;26(1):62-71.
2019-08-06
Cancer-derived VEGF-C increases chemokine production in lymphatic endothelial cells to promote CXCR2-dependent cancer invasion and MDSC recruitment
Cancers. 2019 Aug 6;11(8):Article number 1120.
2019-07
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
Journal of Hematology and Oncology. 2019 Jul;12:Article number 79.
2019-06-24
Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication
Journal of Clinical Medicine. 2019 Jun 24;8(6):Article number 903.
2019-05-27
Deciphering the potential role of hox genes in pancreatic cancer
Cancers. 2019 May 27;11(5):Article number 734.
2019-05-20
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
Molecular Cancer. 2019 May 20;18:Article number 96.
2019-03-21
Two birds, one sone: Double hits on tumor growth and lymphangiogenesis by targeting vascular endothelial growth factor receptor 3
Cells. 2019 Mar 21;8(3):Article number 270.
2019-03
Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis
Oncogene. 2019 Mar;38(12):2005-2019.
2019-01-02
FAK is required for tumor metastasis-related fluid microenvironment in triple-negative breast cancer
Journal of Clinical Medicine. 2019 Jan 2;8(1):Article number 38.
2019-01
Identification of the novel role of CD24 as an oncogenesis regulator and therapeutic target for triple negative breast cancer
Molecular Cancer Therapeutics. 2019 Jan;18(1):147-161.
2019-01
Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
Theranostics. 2019 Jan;9(2):324-336.
2018-12-20
Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression
Cancers. 2018 Dec 20;11(1):Article number 8.
2018-12
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
Cancer Science. 2018 Dec;109(Suppl. 2):866.
2018-11-13
From friend to enemy: Dissecting the functional alteration of immunoregulatory components during pancreatic tumorigenesis
International Journal of Molecular Sciences. 2018 Nov 13;19(11):Article number 3584.
2018-09-15
Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer
American Journal of Cancer Research. 2018 Sep 15;8(9):1812-1822.
2018-09-06
Cell motility facilitated by mono(2-ethylhexyl) phthalate via activation of the AKT-beta-catenin-IL-8 axis in colorectal cancer
Journal of Agricultural and Food Chemistry. 2018 Sep 6;66(37):9635-9644.
2018-02-19
Pyruvate kinase M2 fuels multiple aspects of cancer cells: From cellular metabolism, transcriptional regulation to extracellular signaling
Molecular Cancer. 2018 Feb 19;17:Article number 35.
2018-01
Orchestration of H3K27 methylation: Mechanisms and therapeutic implication
Cellular and Molecular Life Sciences. 2018 Jan;75(2):209-223.
2018-01
The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors
Cancer Science. 2018 Jan;109(Suppl. 1):466.
2017-10-09
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors
Oncotarget. 2017 Oct 09;8(61):103613-103625.
2017-10
The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer
Experimental Cell Research. 2017 Oct;359(2):458-465.
2017-09-16
The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors
Oncotarget. 2017 Sep 16;8(58):98068-98083.
2017-09
G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response
Radiotherapy and Oncology. 2017 Sep;124(3):395-402.
2017-09
KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model
Oncogene. 2017 Sep;36(39):5532-5543.
2017-09
A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients
Scientific Reports. 2017 Sep;7:Article number 11253.
2017-08-07
Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer
Oncogenesis. 2017 Aug 7;6:Article number e369.
2017-08
Fine needle aspiration combined with matrix-assisted laser desorption ionization time-of-flight/mass spectrometry to characterize lipid biomarkers for diagnosing accuracy of breast cancer
Clinical Breast Cancer. 2017 Aug;17(5):373-381.e1.
2016-11
Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer
Journal of Gastroenterology and Hepatology. 2016 Nov;31(Suppl. 3):245.
2016-09
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
Oncotarget. 2016 Sep;7(38):61136-61151.
2016-09
MiR-182 promotes proliferation and invasion and elevates the HIF-1alpha-VEGF-A axis in breast cancer cells by targeting FBXW7
American Journal of Cancer Research. 2016 Sep;6(8):1785-1798.
2016-09
Beta1 integrin as a prognostic and predictive marker in triple-negative breast cancer
International Journal of Molecular Sciences. 2016 Sep;17(9):Article number 1432.
2016-08-31
The oncometabolite R-2-hydroxyglutarate activates NF-kappa B-dependent tumor-promoting stromal niche for acute myeloid leukemia cells
Scientific Reports. 2016 Aug 31;6:Article number 32428.
2016-05-06
Connecting the dots: From DNA damage and repair to Aging
International Journal of Molecular Sciences. 2016 May 6;17(5):Article number 685.
Showing items 1-50 of 88. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback